Electra Therapeutics Upsized IPO Priced at Middle of Views
Dow Jones2026/09/18 09:47By Colin Kellaher
Shares of Electra Therapeutics are set to make their trading debut Friday after the clinical-stage biopharmaceutical company's upsized initial public offering was priced at the midpoint of expectations, raising $350 million.
The South San Francisco, Calif., company late Thursday said it is selling more than 23.3 million shares at $15 each, compared with prior plans to offer nearly 21.7 million shares at between $14 and $16 apiece.
Electra shares are due to begin trading later Friday on the Nasdaq Global Select Market under the symbol ETRA.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
September 18, 2026 05:47 ET (09:47 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
USD/JPY: Japanese growth surprise risk – ING
Truist raises ConocoPhillips target price to $142
BUZZ - Take-Two shares rise after raising annual revenue and profit outlook
Nasdaq 100 Futures Plunge, Decline Expands to 0.4%
Crypto prices
More
